WILLIAM G WIERDA to Aniline Compounds
This is a "connection" page, showing publications WILLIAM G WIERDA has written about Aniline Compounds.
Connection Strength
0.234
-
Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies. Drugs. 2019 Aug; 79(12):1287-1304.
Score: 0.147
-
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease. J Clin Oncol. 2012 Feb 10; 30(5):488-96.
Score: 0.087